Dora Hammerl

Company: Pan Cancer T

Job title: Vice President Research & Development, Co-Founder

Seminars:

1:00 pm Workshop B:
Exploring Next Generation Combination & Armoring Technology to Improve Efficacy of Cell Therapy 9:00 am

With new approvals, partnerships and investments in the cell therapy field the most important thing is to utilize and innovate the latest technology to ensure success and stay ahead of the curve. Next generation armoring, combination and gene editing technologies are the best way forward. Join this workshop to: Review CRISPR, next-generation sequencing and other…Read more

day: Workshop Day Track A P2